Silexan for treatment of psychiatric manifestations in the context of COVID-19: a case series

INTRODUCTION: Silexan manufactured from Lavandula angustifolia showed favorable safety and efficacy in subthreshold and generalized anxiety disorder (GAD), mixed anxiety and depressive disorder (MADD), and further, especially subsyndromal psychiatric manifestations including depression, sleep distur...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartova, L., Dold, M., Fugger, G., Weidenauer, A., Rujescu-Balcu, D., Kasper, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479386/
http://dx.doi.org/10.1192/j.eurpsy.2023.1690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479386/
http://dx.doi.org/10.1192/j.eurpsy.2023.1690

Ejemplares similares